
Sign up to save your podcasts
Or


President Trump has announced he will impose a 100% tariff on chips and semiconductors imports, although he’s suggested exemptions for companies manufacturing in the U.S. One company that may qualify for that exemption: Apple. During CEO Tim Cook’s meeting with the President on Wednesday, Cook committed an additional $100 billion to onshore manufacturing. Author Walter Isaacson discusses Cook’s commitment in the context of Steve Jobs’ original plans to manufacture Apple products in America. President Trump also has another tech CEO in his sights, calling for the resignation of Intel’s Lip-Bu Tan on social media. CNBC’s Angelica Peebles reveals the latest obesity pill trial results from Eli Lilly. Orfoglipron’s results were similar to Wegovy, and investors are disappointed by the data and the rate of discontinuation among trial participants. Plus, Lyft CEO David Risher explains his company’s earnings report, strong on paper but disappointing to some investors.
Megan Cassella - 5:35
Angelica Peebles - 13:03
Walter Isaacson - 20:47
David Risher - 35:21
In this episode:
Megan Cassella, @mmcassella
Angelica Peebles, @angelicapeebles
Joe Kernen, @JoeSquawk
Andrew Ross Sorkin, @andrewrsorkin
Melissa Lee, @MelissaLeeCNBC
Katie Kramer, @Kramer_Katie
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.2
525525 ratings
President Trump has announced he will impose a 100% tariff on chips and semiconductors imports, although he’s suggested exemptions for companies manufacturing in the U.S. One company that may qualify for that exemption: Apple. During CEO Tim Cook’s meeting with the President on Wednesday, Cook committed an additional $100 billion to onshore manufacturing. Author Walter Isaacson discusses Cook’s commitment in the context of Steve Jobs’ original plans to manufacture Apple products in America. President Trump also has another tech CEO in his sights, calling for the resignation of Intel’s Lip-Bu Tan on social media. CNBC’s Angelica Peebles reveals the latest obesity pill trial results from Eli Lilly. Orfoglipron’s results were similar to Wegovy, and investors are disappointed by the data and the rate of discontinuation among trial participants. Plus, Lyft CEO David Risher explains his company’s earnings report, strong on paper but disappointing to some investors.
Megan Cassella - 5:35
Angelica Peebles - 13:03
Walter Isaacson - 20:47
David Risher - 35:21
In this episode:
Megan Cassella, @mmcassella
Angelica Peebles, @angelicapeebles
Joe Kernen, @JoeSquawk
Andrew Ross Sorkin, @andrewrsorkin
Melissa Lee, @MelissaLeeCNBC
Katie Kramer, @Kramer_Katie
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,060 Listeners

3,213 Listeners

1,352 Listeners

239 Listeners

150 Listeners

1,170 Listeners

321 Listeners

67 Listeners

153 Listeners

2,162 Listeners

2,116 Listeners

588 Listeners

20 Listeners

10,018 Listeners

1,566 Listeners

210 Listeners

402 Listeners

302 Listeners

119 Listeners

810 Listeners

59 Listeners

156 Listeners

37 Listeners

14 Listeners

30 Listeners

10 Listeners

16 Listeners